Viruses are obligate intracellular pathogens that infect host cells by attaching to receptors, penetrating the cell, and releasing their nucleic acid to hijack the cell's machinery to replicate. The immune system responds to viral infections with nonspecific defenses like interferons and natural killer cells, and specific defenses using antibodies and T cells. However, viruses have evolved mechanisms to escape the immune response such as antigenic variation, evading detection through latency, inhibiting immune signaling pathways, and suppressing antigen presentation.
Viruses are obligate intracellular pathogens that infect host cells by attaching to receptors, penetrating the cell, and releasing their nucleic acid to hijack the cell's machinery to replicate. The immune system responds to viral infections with nonspecific defenses like interferons and natural killer cells, and specific defenses using antibodies and T cells. However, viruses have evolved mechanisms to escape the immune response such as antigenic variation, evading detection through latency, inhibiting immune signaling pathways, and suppressing antigen presentation.
Viruses are obligate intracellular pathogens that infect host cells by attaching to receptors, penetrating the cell, and releasing their nucleic acid to hijack the cell's machinery to replicate. The immune system responds to viral infections with nonspecific defenses like interferons and natural killer cells, and specific defenses using antibodies and T cells. However, viruses have evolved mechanisms to escape the immune response such as antigenic variation, evading detection through latency, inhibiting immune signaling pathways, and suppressing antigen presentation.
Viruses are obligate intracellular pathogens that infect host cells by attaching to receptors, penetrating the cell, and releasing their nucleic acid to hijack the cell's machinery to replicate. The immune system responds to viral infections with nonspecific defenses like interferons and natural killer cells, and specific defenses using antibodies and T cells. However, viruses have evolved mechanisms to escape the immune response such as antigenic variation, evading detection through latency, inhibiting immune signaling pathways, and suppressing antigen presentation.
Introduction Virus • Submicroscopic pathogens whose size is measured in nanometers • Their basic structure consists of a core of DNA or RNA packaged into a protein coat or capsid • In some viruses, the capsid is surrounded by an outer envelope of glycolipids and proteins derived from the host cell membrane • Capable of causing severe, and sometimes lethal, disease in humans, ranging from childhood infections to inflammatory diseases with a predilection for a specific organ, disseminated disease in immunocompromised patients, cancer, and congenital abnormalities Basic structure of virus • Viruses are obligate intracellular pathogens that rely on the host cell for their replication and survival. • They infect their host cells by • Attaching to specific receptors on the cell surface; • Penetrating the host cell membrane; and releasing their nucleic acid • which then directs the host cell’s machinery to produce more viral nucleic acid and proteins. • These components assemble to form intact viruses that are released by lysis of the cell or by budding off the cell’s surface Basic step of a virus life cycle Immune defense against viral infection
• Two important nonspecific defenses against viruses involve
type I interferons and natural killer (NK) cells • Virus-infected cells are stimulated to produce IFN-α and IFN-β following recognition of viral RNA by toll-like receptors (TLR) • Interferons inhibit viral replication by inducing the transcription of several genes that code for proteins with antiviral activity • IFN-α and IFN-β also enhance the activity of NK cells, which bind to virus-infected cells and release cytotoxic proteins such as perforin and granzymes, causing the cells to die and release the viruses • When innate defenses are insufficient in preventing viral infection, specific humoral and cell-mediated defenses are activated. • Virus-specific antibodies are produced by B cells and plasma cells and can attack free virus particles in several ways. • Antibodies play a key role in preventing the spread of a viral infection through neutralization • Secretory IgA antibodies play an especially important role in this process because they neutralize viruses in the mucosal surfaces • IgM and IgG antibodies can bind to viruses in the bloodstream and inhibit dissemination of the infection. • IgG antibodies promote phagocytosis of viruses through their opsonizing activity and promote destruction of viruses through antibody-dependent cell-mediated cytotoxicity (ADCC) • IgM antibodies may also inactivate viral particles by agglutinating them • Elimination of intracellular viruses requires the action of cell-mediated immunity. • Type 1 helper (Th1) cells and cytotoxic T lymphocytes (CTL) play a key role in this mechanism of defense. • Th1 cells produce interferon-γ, which induces an antiviral state within the virus-infected cells, and IL-2, which assists in the development of effector CTLs • To recognize the virus infected host cell, the T-cell receptor (TCR) on the CTL must bind to a viral antigen complexed with class I major histocompatibility complex (MHC) on the surface of the infected cell • CD8 is a co-receptor in this interaction. Interaction of costimulatory molecules, such as B7 and CD28, provides secondary signals necessary for the CTL response. • These molecular interactions stimulate the granules in the CTL to release a pore-forming protein called perforin, which produces pores in the membrane of the infected host cell, and proteases called granzymes, which enter the pores.
• These enzymes activate apoptosis in the host cell, interrupting
the viral-replication cycle and resulting in release of assembled infectious virions. The free virions can then be bound by antibodies.
• The CTL response is powerful and involves a series of cell
divisions that can produce up to 50,000 times the original number of cells in a period of 1 to 3 weeks Viral immune escape mechanism
• Viruses are rapidly dividing agents that undergo frequent
genetic mutations • These mutations result in the production of new viral antigens, which are not recognized by the initial immune response to the virus • For example, continual antigenic variation in the influenza virus results in the emergence of novel infectious strains that require development of new vaccines every year to protect the population. • Antigenic variation is also seen in other viruses, including rhinoviruses, which cause the common cold, and HIV, which causes AIDS Viral immune escape mechanism
• Some viruses can escape the action of components of
the innate immune system such as interferons, complement proteins, or the lysosomal enzymes in phagocytic cells.
• For example, the hepatitis C virus can block
interferon-mediated degradation of viral RNA and herpes simplex viruses (HSV) produce a protein that binds to the complement component, C3b,resulting in inhibition of the complement pathways • Viruses can evade the host’s defense by suppressing the adaptive immune system. • Some viruses, such as the cytomegalovirus (CMV) and HIV, do this by reducing the expression of class I MHC molecules on the surface of virus-infected cells, making them less likely to be recognized by CTLs. • Other viruses, such as rubeola, can cause decreased expression of class II MHC molecules, resulting in reduced Th cell activity. • Some viruses can alter the function of certain cells of the immune system after directly infecting them. • For example, the Epstein-Barr virus (EBV) causes polyclonal activation in B lymphocytes, whereas HIV suppresses the function of CD4 Th cells. • EBV can also inhibit immune responses by producing a protein that can suppress Th1 cells because of its similarity to interleukin- 10 (IL-10) • Some viruses, such as CMV, varicella-zoster virus (VZV), and HIV, can remain in a latent state by integrating their nucleic acid into the genome of the infected host cells.
• In this situation, the virus is only stimulated to replicate again
if the host is exposed to other infectious agents or if the host’s immune defenses decline.
• Latent viruses can remain silent within host cells for years because they are hidden from the immune system, although reactivation can occur later in life End